Culturing MOC1 and MOC22 Oral Cancer Cells

MOC1 and MOC22 oral cancer cells (33 (link)) were kindly provided by R. Uppaluri, Dana Farber Cancer Institute, Boston, MA and cultured in Iscove's modified Dulbecco's media/IMDM/Ham’s F-12 media containing 0.016 g/L tryptophan (Fisher Scientific). Culture details are described in SI Appendix.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Kenison J.E., Wang Z., Yang K., Snyder M., Quintana F.J, & Sherr D.H. (2021). The aryl hydrocarbon receptor suppresses immunity to oral squamous cell carcinoma through immune checkpoint regulation. Proceedings of the National Academy of Sciences of the United States of America, 118(19), e2012692118.

Publication 2021

tryptophan

Cancer Cells Cultured media Oral cancer Tryptophan

Corresponding Organization : Boston University

Other organizations : Brigham and Women's Hospital, Harvard University, Broad Institute

Top 5 similar protocols

Variable analysis

independent variables

MOC1 and MOC22 oral cancer cells

dependent variables

Not explicitly mentioned

control variables

Media composition (Iscove's modified Dulbecco's media/IMDM/Ham's F-12 media containing 0.016 g/L tryptophan)

controls

None explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!